Novel Coronavirus
Showing 51 - 75 of >10,000
DoD Health System
Not yet recruiting
- COVID-19; SARS-CoV-2; 2019 Novel Coronavirus Disease
- (no location specified)
Oct 4, 2022
Gastric Cancer Trial in Xi'an (Penpulimab combined with Anlotinib Hydrochloride Capsules and chemo;Cadonilimab combined with
Not yet recruiting
- Gastric Cancer
- Penpulimab combined with Anlotinib Hydrochloride Capsules and chemotherapy;Cadonilimab combined with Anlotinib Hydrochloride Capsules and chemotherapy
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Air Force Military Medical Univ
Mar 23, 2023
Coronavirus Disease 2019 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell) group)
Completed
- Coronavirus Disease 2019
- Recombinant new coronavirus vaccine (CHO cell) group
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 21, 2021
COVID-19 Trial in Miami (NP-101, Placebo)
Recruiting
- COVID-19
- NP-101
- Placebo
-
Miami, FloridaL&A Morales Healthcare/ Enrique Villa, MD Principal Investigator
Mar 23, 2023
COVID-19 Trial in Nanjing (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation, Recombinant Novel
Recruiting
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincal Center for Disease Control and Prevention
Jul 27, 2021
2019 Novel Coronavirus Trial in Amman (HCQ01, standard of care (SOC) for COVID-19)
Not yet recruiting
- 2019 Novel Coronavirus
- HCQ01
- standard of care (SOC) for COVID-19
-
Amman, JordanKing Hussein Cancer Center
Jun 25, 2022
Covid19 Trial in Caba, Capital Federal (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV))
Recruiting
- Covid19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV)
-
Caba, Buenos Aires, Argentina
- +3 more
Sep 14, 2021
Depression, Burnout, Professional, Post Traumatic Stress Disorder Trial in Tours (EMDR)
Active, not recruiting
- Depression
- +2 more
- EMDR
-
Tours, Centre Val De Loire, France
- +1 more
Jan 23, 2023
Pharmacokinetics, Safety Issues, Efficacy Trial in Russian Federation (GP30341 capsules 200 mg, Standard therapy)
Completed
- Pharmacokinetics
- +2 more
- GP30341 capsules 200 mg
- Standard therapy
-
Kaliningrad, Russian Federation
- +4 more
Dec 7, 2022
Coronavirus, N95, Medical Mask Trial in Canada, Israel (Medical Mask, N95 respirator)
Completed
- Coronavirus
- +2 more
- Medical Mask
- N95 respirator
-
Calgary, Alberta, Canada
- +14 more
Jan 11, 2023
Covid19 Trial in Shijiazhuang (Novel coronavirus infection)
Completed
- Covid19
- Novel coronavirus infection
-
Shijiazhuang, Hebei, ChinaShijiazhuang Fifth Hospital
Jun 11, 2021
Asthenia, COVID-19 Trial in Russian Federation (Ethyl methyl hydroxypyridine succinate + Meldonium, Placebo)
Completed
- Asthenia
- COVID-19
- Ethyl methyl hydroxypyridine succinate + Meldonium
- Placebo
-
Moscow, Russian Federation
- +5 more
Jan 18, 2023
Covid19 Trial in Ashkelon (Breath biopsy sampling using the ReCIVA Breath Sampler)
Completed
- Covid19
- Breath biopsy sampling using the ReCIVA Breath Sampler
-
Ashkelon, IsraelIDF COVID 19 Isolation Facility
Feb 3, 2022
COVID-19 Trial in Wuhan (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector))
Completed
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
-
Wuhan, Hubei, ChinaHubei Provincial Center for Disease Control and Prevention
Aug 2, 2021
Covid19 Trial in San Diego, Hialeah, Houston (TQ Formula/Tab)
Completed
- Covid19
- TQ Formula/Tab
-
San Diego, California
- +2 more
Mar 23, 2022
Covid19, Hydrogen-oxygen Gas, AMS-H-03 Trial in Shanghai (Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03, the hospital
Active, not recruiting
- Covid19
- +2 more
- Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03
- the hospital routine oxygen supply equipment (wall oxygen or cylinder oxygen)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Medical School of Shanghai Jiaotong University
Sep 13, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,
Terminated
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Newport Beach, California
- +14 more
Jul 20, 2022
SARS-CoV-2 Infection Trial in Washington (Coronavirus-specific T cell (CST))
Recruiting
- SARS-CoV-2 Infection
- Coronavirus-specific T cell (CST)
-
Washington, District of Columbia
- +1 more
Sep 1, 2022
PHenotyping patiENts Admitted to Hospital With cOvid-19
Recruiting
- Coronavirus
- +4 more
-
London, United KingdomChelsea and Westminster Hospital
Aug 5, 2021
2019 Novel Coronavirus Trial in Amman (HCQ01, standard of care (SOC) for COVID-19)
Recruiting
- 2019 Novel Coronavirus
- HCQ01
- standard of care (SOC) for COVID-19
-
Amman, JordanPrince Hamza Hospital/ Amman Field Hospital
Mar 2, 2022
Covid19, ME/CFS, SARS COV2 Trial in United States
Active, not recruiting
- Covid19
- +5 more
-
Los Angeles, California
- +7 more
Sep 1, 2022
Covid19 Trial in Russian Federation (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Placebo)
Active, not recruiting
- Covid19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
- Placebo
-
Ekaterinburg, Russian Federation
- +6 more
Jul 19, 2021
Novel Coronavirus Pneumonia Trial (Tanreqing capsule, Tanreqing capsule simulator)
Not yet recruiting
- Novel Coronavirus Pneumonia
- Tanreqing capsule
- Tanreqing capsule simulator
- (no location specified)
Apr 5, 2022
Associated Skin Lesions Trial in Hangzhou (Ointment and dressing for external use)
Active, not recruiting
- Associated Skin Lesions
- Ointment and dressing for external use
-
Hangzhou, Zhejiang, ChinaDressing
Jun 2, 2021
Pneumonia, Viral, Covid-19 Trial in Greece (UNIKINON (Chloroquine phosphate) 200mg tablets)
Terminated
- Pneumonia, Viral
- Covid-19
- UNIKINON (Chloroquine phosphate) 200mg tablets
-
Athens, Greece
- +7 more
Sep 16, 2021